AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

HERON THERAPEUTICS, INC. /DE/ Director's Dealing 2012

Sep 17, 2012

33572_dirs_2012-09-17_975a881b-dc3c-4ff7-b4d4-450b24790837.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AP PHARMA INC /DE/ (APPA)
CIK: 0000818033
Period of Report: 2012-07-25

Reporting Person: SPCH, LLLP (10% Owner)
Reporting Person: Midler Andrew R (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
A.P. Pharma Common Stock $0.010 par value	36190476	Direct